Protection Analysis

Panacea community - Protection sales by quarter 

Product Q3 18 Q4 18 Q1 19 Q2 19 Grand total
Crit. Illness £1,246,942 £3,698,083 £4,065,128 £4,124,738 £13,134,891
Decreasing Term with CI £4,054,829 £3,563,227 £3,140,952 £3,568,386 £14,327,394
Income Prot. £3,030,964 £4,947,888 £3,313,355 £3,322,414 £14,614,621
Mortgage Term £7,311,975 £7,022,608 £6,335,576 £6,260,505 £26,930,665
Relevant Life £2,027,087 £2,244,089 £2,260,620 £2,741,431 £9,273,227
Term £17,652,617 £16,403,565 £16,727,886 £16,420,668 £67,204,737
Term with Critical Illness £5,281,881 £5,471,370 £6,010,992 £6,037,930 £22,802,173
Whole of Life £5,529,934 £4,271,921 £4,343,582 £3,685,223 £17,830,660

 

Q2 18 to Q1 19 total Protection sales 

Product Non-user Sales (£) Panacea Community Sales (£) Total Market Share
Crit. Illness £26,249,437 £13,134,891 £39,384,328 33%
Decreasing Term with CI £37,063,447 £14,327,394 £51,390,840 28%
Income Prot. £33,181,646 £14,614,621 £47,796,267 31%
Mortgage Term £76,142,683 £26,930,665 £103,073,348 26%
Relevant Life £10,316,328 £9,273,227 £19,589,555 47%
Term £157,226,467 £67,204,737 £224,431,204 30%
Term with Critical Illness £58,390,445 £22,802,173 £81,192,619 28%
Whole of Life £22,417,055 £17,830,660 £40,247,714 44%

 

Please contact sarahpaul@panaceaadviser.com if you are interested in speaking to us further.

Email this article Print Share on Twitter Share on LinkedIn Share on Facebook Share on Google+